MedTrace Logo

Intra Testicular Artery Injection of Bone Marrow Stem Cell in Management of Azoospermia

NCT02008799 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-04-08

No results posted yet for this study

Summary

Azoospermia due to low sperm production (non-obstructive azoospermia) affects approximately 1% of the male population and 10% of men who seek fertility evaluation. Testis biopsy reveals that these men have Sertoli cell-only pattern, maturation arrest, or hypospermatogenesis. Until recently, it was assumed that men with non-obstructive azoospermia were untreatable. Indeed, these patients were often referred to as being "sterile" or having "testicular failure." We start to use stem cell in treatment of such patients by injecting the stem cell at the testis and the testicular artery in one group and at the testis only in other group

Conditions

  • Azoospermia

Interventions

PROCEDURE

Bone marrow stem cell injection

Injection should be in testis and testicular artery

Sponsors & Collaborators

  • Man Clinic for Andrology, Male Infertility and Sexual Dysfunction

    lead OTHER

Principal Investigators

  • Khaled A Gadalla, MD · Man Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2016-03-31
Completion
2016-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02008799 on ClinicalTrials.gov